MERRF syndrome: Difference between revisions
CSV import |
CSV import |
||
| Line 60: | Line 60: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Ragged_red_fibers_in_MELAS.jpg|Ragged red fibers in MELAS | |||
File:Mitochondrial.svg|Mitochondrial | |||
</gallery> | |||
Revision as of 01:47, 17 February 2025
MERRF syndrome (or Myoclonic Epilepsy with Ragged Red Fibers) is a mitochondrial disease that affects many parts of the body, particularly the muscles and nervous system. The condition is characterized by myoclonus, which is a type of seizure that causes rapid, uncontrolled muscle jerks. Other common features of MERRF syndrome include ataxia, a problem with coordination and balance, and muscle weakness.
Symptoms
The symptoms of MERRF syndrome can vary widely in severity, age of onset, and the organs affected. Most individuals with MERRF syndrome show signs of the disorder in childhood or adolescence, but features of the condition can appear anytime throughout life. The most common symptoms include:
- Myoclonus
- Ataxia
- Muscle weakness
- Hearing loss
- Peripheral neuropathy
- Dementia
- Short stature
- Exercise intolerance
Causes
MERRF syndrome is caused by mutations in the mitochondrial DNA. The most common mutation associated with MERRF syndrome replaces the DNA building block (nucleotide) adenine with guanine at position 8344 (written as A8344G). This mutation occurs in a gene that provides instructions for making a molecule called transfer RNA (tRNA), which is essential for assembling the protein building blocks (amino acids) that are needed to make proteins.
Diagnosis
The diagnosis of MERRF syndrome is based on a clinical examination, the identification of characteristic symptoms, a detailed patient history, and a variety of specialized tests. These tests can include:
Treatment
There is currently no cure for MERRF syndrome. Treatment is symptomatic and supportive, and may include:
Prognosis
The prognosis for individuals with MERRF syndrome varies greatly and depends on the specific symptoms and severity in each person. Some individuals may live into adulthood with mild symptoms, while others may experience a more rapid progression of symptoms and a shortened lifespan.
